3171 results for «291»

Filter By

3171 results

Challenging TAVI scenarios

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session is for you if you want to learn more about recurrent valve migration during TAVR or TAVI with permanent pacemaker implantation, among others!

Challenging TAVI scenarios

Challenging CTO cases - Session 2

14 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session compiles 5 challenging CTO cases and explains how to handle them. Study for example a flush ostial RCA-CTO, PWS in a CTO feeding vessel, rotablation and intravascular lithotripsy in three-vessel disease with IVUS, or rotaburr incarceration.

Challenging CTO cases - Session 2

The why and how of performing a successful TAVI case

14 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, observe a 72-year-old male patient with NYHA class II exertional dyspnoea, CAD status after revascularisation, type II DM, CKD IIIB, recently admitted for decompensated HF and type II NSTEMI, who was referred to the clinic for aortic valve replacement.

The why and how of performing a successful TAVI case

Challenging ACS scenarios

14 Dec 2022 – From GulfPCR-GIM 2022

Topics in this GulfPCR-GIM 2022 session include the role of imaging in an unusual case of ACS in a young patient, PCI of an abnormal left coronary artery with AMI, embolisation of a thrombus in a non-culprit vessel during PCI in a late-presenting anterior STEMI, and...

Challenging ACS scenarios

PCI in stable CAD

14 Dec 2022 – From GulfPCR-GIM 2022

Study the two cases presented in this GulfPCR-GIM 2022 session to find out more about the importance of proper monitoring in detecting post-PCI complications and managing complex PCI and coronary stent loss.

PCI in stable CAD

Bifurcation lesion

14 Dec 2022 – From GulfPCR-GIM 2022

Among the 3 bifurcation lesion cases presented in this GulfPCR-GIM 2022 session, find out how to deliver a trapped guidewire, how to manage a live angioplasty that turned out to be a nightmare, and how to deal with a multivessel intervention with left main bifurcation and...

Bifurcation lesion

Ultrasound supported thrombolysis: a live-saving procedure in massive saddle pulmonary embolism

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to learn how and why minimally invasive catheter directed thrombolytic therapy assisted by ultrasound can be effective and safe, even in massive pulmonary embolism with compromised RV function.

Ultrasound supported thrombolysis: a live-saving procedure in massive saddle pulmonary embolism

Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)

07 Nov 2024

Aaysha Cader provides her take on the DRAMI trial presented by Jun-Won Lee at TCT 2024 in Washington.

Author

Aaysha Cader
Comparison of puncture success rate between distal radial access and transradial access in patients with STEMI (DRAMI)

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?